This is the mail archive of the
ecos-bugs@sources.redhat.com
mailing list for the eCos project.
BioTechnology Alert for Monday
- From: "Krystal Angelina" <acty at hinet dot net>
- To: <crossgcc-help at sources dot redhat dot com>
- Date: Sat, 23 Jul 2005 20:27:50 -0800
- Subject: BioTechnology Alert for Monday
BIOTECHNOLOGY NEWS..... MONDAY JULY 25 WATCH
. RADAR ALERT ....RADAR ALERT.....RADAR ALERT.....RADAR ALERT
Pacific Sunset Investments Inc.
SYMBOL: PSIV
CURRENT PRICE: .24
SHORT-TERM: $1.00
How many times have you heard about this????
adverse drug reactions accounted for more than 2.2 million serious cases and
over 100,000 deaths,
PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV
A study published in the Journal of the American Medical Association
reported that adverse drug reactions accounted for more than 2.2 million
serious cases and over 100,000 deaths, making adverse drug reactions (ADRs)
one of the leading causes of hospitalization and death in the United States.
Breaking News for Pacific Sunset Investments
Pacific Sunset Investments Completes Gen ID Acquisition
HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--May 20, 2005--Pacific Sunset
Investments, Inc. ("Pacific Sunset") (OTC:PSiV announced that it has
completed its acquisition of Gen-ID Lab Services, LLC, a California limited
liability corporation specializing in Single Nucleotide Polymorphism
analysis data. In addition, the board of directors of Pacific Sunset has
appointed Douglas Freedman to its board of directors with experience in
marketing. Additionally, the company has appointed Dr. Steve N. Slilaty,
Ph.D., to head an Advisory Board to assist the company with reviewing new
alternatives in the "SNP" field of technology.
Gen ID will provide "SNP" (Single Nucleotide Polymorphism) analysis data.
The results of SNP analysis provide physicians with a more enlightened
choice of drugs and they will also be able to predict the effectiveness of
the drugs for individual patients. The use of an SNP test to help treat
childhood leukemia is currently being used by doctors and hospitals in the
United States.
Dr. Steve Slilaty is President and Chief Scientific Officer of Advanomics
Corporation, a leading-edge biotechnology company focusing on the
identification of disease related molecular targets using advanced
transriptomics technologies, which he recently developed. Dr. Slilaty also
is an Adjunct Professor at the Universite du Quebec in the department of
Microbiology and Biotechnology. Dr. Slilaty has founded three biotechnology
companies, Advanomics Corporation, Quantum Biotechnologies Inc. (now known
as Qbiogene Inc.) and Geneomics One Corporation. In addition, Dr. Slilaty is
one of the pioneers of Gene Therapy, having developed the first Gene
Transfer system in 1983.
(This is a partial clip of the news. We suggest you go read the whole
release. Our opinion is, this is important technology. Go to yahoo or any
financial site and read the news)
CONCLUSION:
adverse drug reactions accounted for more than 2.2 million serious cases and
over 100,000 deaths, Doesn't this say it all?
A company to watch!
AGGRESSIVE INVESTORS TAKE NOTE NOW!
PUT Pacific Sunset Investments Inc. PSiV
ON YOUR RADAR SCREENS NOW,
AND WATCH THIS COMPANY STARTING NOW
its population at least 2500 people I don't
think there's ever been a tragedy that affected
the heartbeat held the news conference at the
end of their first
day in Thailand The BBC's Chris Hogg in
Phuket says it was quite a sight to
see the two former v presidents tramping through the
dirt in Baan Nam Khem to see the v
devastation for themselves So
far only 400 foreigners' bodies have been identified
A couple of hundred of the survivors came
down to the shore to see Mr Bush v
and Mr Clinton who talked to fishermen who
had lost their boats and their livelihoods The
two former leaders also inspected the first of
200 new houses being completed They was speaking
after meeting a highlevel Togolese delegation in Nigeria
Rival rallies Under the
original constitution which was amended to legitimise Mr
Faure's installation the parliamentary speaker should hold the
presidency pending the election The opposition wants the
new leader to step
down immediately In Togo itself rival demonstrations by
critics and supporters of the new leader passed
off peacefully on Saturday At least 10000 opposition
demonstrators marched through the streets of the capital
Lome Many carried placards denouncing the new leader
as a "thief" who had stolen power Thousands v
of ruling party supporters gathered separately at the
president's residence and said they would support him v v
in the polls Mr Faure addressed them restating v v
his determination to hold